Generics

We manufacture our products by following our customers’ and health authorities’ most stringent requirements. DMF documentation for all our products is prepared in accordance with the latest requirements 
of EDQM (CEP), ICH (ASMF in eCTD format), and FDA (US DMF). Material and product testing is performed in line with the European and United States Pharmacopeias.

Search for product

abcdefghijklmnoprstuvxyz

Filters

API Status

CommercialPipeline

Nervous system

Alimentary tract & metabolismAntifungal agentAnti-infectives for systemic useAntipyretic, analgesic and anti-inflammatoryAntineoplastic & immunomodulating agentsBlood & blood forming organsCardiovascular systemGenito-urinary system & sex hormonesInjectable FormsMusculo-skeletal systemOpthalmological preparationsRespiratory systemOncology

Available EU DMF/CEP/US DMF

Injectable Forms

Reset filters

API product & pipeline (pdf)

Sort by

Alphabetical Therapeutic Category

Sort:

Alphabetical Therapeutic Category

Status

Therapeutic Category

Polymorphic form

CAS No.

    A

  • Aniracetam

    StatusCommercial

    Therapeutic CategoryNervous system

    Polymorphic formMonoclinic form

    CAS No.72432-10-1

    View more

  • Aripiprazole

    StatusCommercial

    Therapeutic CategoryNervous system

    Polymorphic formType I

    CAS No.129722-12-9

    View more

  • Aripiprazole monohydrate non-sterile

    StatusCommercial

    Therapeutic CategoryNervous system

    Polymorphic formMonohydrate

    CAS No.851220-85-4

    View more
    • B

  • Brexpiprazole

    StatusPipeline

    Therapeutic CategoryNervous system

    Polymorphic formForm I

    CAS No.913611-97-9

    View more
    • C

  • Carbamazepine

    StatusCommercial

    Therapeutic CategoryNervous system

    Polymorphic formForm III

    CAS No.298-46-4

    View more
    • L

  • Lamotrigine

    StatusCommercial

    Therapeutic CategoryNervous system

    Polymorphic formAnhydrous monoclinic

    CAS No.84057-84-1

    View more
    • O

  • Opipramol dihydrochloride

    StatusCommercial

    Therapeutic CategoryNervous system

    Polymorphic formAmorphous

    CAS No.909-39-7

    View more

  • Oxcarbazepine

    StatusCommercial

    Therapeutic CategoryNervous system

    Polymorphic formForm A

    CAS No.28721-07-5

    View more
    • P

  • Pimavanserin tartrate

    StatusPipeline

    Therapeutic CategoryNervous system

    Polymorphic formCrystalline anhydrous form C

    CAS No.706782-28-7

    View more

  • Piracetam

    StatusCommercial

    Therapeutic CategoryNervous system

    Polymorphic formForm II

    CAS No.7491-74-9

    View more
    • S

  • Safinamide methanesulfonate

    StatusPipeline

    Therapeutic CategoryNervous system

    Polymorphic formCrystalline anhydrous form A1

    CAS No.202825-46-5

    View more
    • T

  • Topiramate

    StatusCommercial

    Therapeutic CategoryNervous system

    Polymorphic formOrthorhombic structure

    CAS No.97240-79-4

    View more